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Mediastinal pure choriocarcinomas are exceedingly rare representations of germ cell tumours and are associated with a poor
prognosis. To date, fewer than 20 cases have been reported. This current report describes an elderly patient who developed a
large rapidly growing mediastinal tumour. Unfortunately, the patient expired before a definitive diagnosis could be reached. An
autopsy revealed that the histomorphological features of the tumour showed two distinct tumour cell populations (syncytio- and
cytotrophoblasts), and the diagnosis of choriocarcinomawasmade. Immunohistochemical analysis showed a characteristic staining
pattern in agreementwith published studies. Here, we report a case of primarymediastinal choriocarcinoma in an elderlymale with
concurrent metastasizing prostate adenocarcinoma treated with long-term goserelin deposits, which, as we speculate, could have
induced the choriocarcinoma.
1. Case Report
Choriocarcinoma is a rare malignant tumour that most
commonly develops from the chorionic part of the placenta.
In males, it is most commonly seen in the testes as part
of a mixed germ cell tumour in young males. Extragonadal
occurrence is rare—preferentially in axial structures, such as
the mediastinum, retroperitoneum, and brain. The prognosis
ofmediastinal choriocarcinoma is usually poor, which under-
lines the necessity of rapid diagnosis [1].
We report here a rare case of primary mediastinal chori-
ocarcinoma in an elderly patient with concurrent goserelin-
treated metastasized prostate adenocarcinoma.
A 71-year-old man presented with a 5-week history of
severe back pain. Five years earlier, the patient was diag-
nosed with metastatic prostate adenocarcinoma (Gleason
score 4+4) and was treated with gonadotropin releasing
hormone (GNRH) agonist implants (goserelin, 10.8 mg).
After 9 months of treatment, prostate specific antigen (PSA)
values returned to normal levels.
Upon admission, bone scintigraphy showed no bone
metastases but a potential compression fracture of the L2 ver-
tebra. CT-scan confirmed a lesion in L2 and revealed a 5-cm
spherical tumour located in the anterior mediastinum and
multiple lung metastases. The periphery of the mediastinal
tumour had high levels of Fludeoxyglucose metabolism as
seen on PET-CT.The lung metastases and L2 were also PET-
positive. Needle biopsy from the mediastinal tumour showed
necrosis but no tumour cells. Decompressive laminectomy
was performed, and suspected tumour tissue was sent for
histological examination. Unfortunately, the patient expired
before any conclusive diagnosis could be reached and therapy
instituted.
Autopsy revealed a 5.5 cm spherical tumour in the
mediastinum adherent to but not invading the left lung. The
lung parenchyma bilaterally contained multiple suspected
metastases. The prostate was slightly enlarged but showed
no macroscopical signs of adenocarcinoma. Both testes were
atrophic and without signs of focal lesions.
The extensive microscopic examination of the mediasti-
nal tumour revealed widespread necrosis and peripheral
areas with two distinct tumour cell populations (syncytio-
and cytotrophoblasts) (Figure 1). Morphologically, the medi-
astinal tumour and the metastasis in the lung and lum-
bar vertebra were a pure choriocarcinoma. The tumour
was extensively characterized by immunohistochemistry and
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Table 1: Immunohistochemical expression profile.
hCG Inhibin OCT3/4 SALL4 GLP3 GATA3 CD71 CK7 p63
Syncytiotrophoblast cells pos pos neg neg pos pos pos pos neg
Cytotrophoblast cells pos neg neg pos neg pos pos pos pos
Figure 1: Left: HE stained section of choriocarcinomametastasis in
L2. Right: the same section stained immunohistochemically for p63.
Positive reaction (brown) in the nuclei of the cytotrophoblast cells.
showed binary expression of diagnostic markers (Table 1).
Microscopic evaluation of the prostate revealed small areas
(5% of the total volume) with residual adenocarcinoma.
On the basis of the findings above, we concluded that the
tumour was a primary mediastinal choriocarcinoma.
2. Discussion
The origin of extragonadal choriocarcinomas has been
debated [2]. They have been suggested to develop from
foci of pluripotent cells in the axial structures or to be
metastases from a testicular tumour. In a case series of
eight primary mediastinal choriocarcinomas, no primary
lesions were found in the testes suggesting the existence
of true primary mediastinal choriocarcinomas [1]. As we
unfortunately did not perform microscopic examination of
the testes, this case does not shed further light on this issue.
Diagnosis of extragonadal choriocarcinomas can be chal-
lenging due to samples comprising predominantly necrosis
but only small amounts of tumour cells suitable for diagnosis.
Immunohistochemical markers can often promote correct
diagnosis.
Our findings are similar to previously published immun-
ohistochemical studies of choriocarcinomas. The tumour
was classically positive for hCG. The germ cell markers
SALL4 and glypican 3 exhibited a characteristic binary
staining pattern (Table 1) [3, 4]. One group found glypican
3 strongly positive in the syncytiotrophoblasts, while the
cytotrophoblasts wereweakly positive [3]. Although the latter
result deviates from our findings, we still observed a binary
staining pattern. This difference may in part be explained by
a different staining methodology. In agreement with a study
of 11 choriocarcinomas, GATA3 was positive in both tumour
cell subpopulations [5]. In concurrence with a recent article,
syncytiotrophoblast cells were positive for inhibin and CK7,
while cytotrophoblast cells were positive for inhibin, p63, and
CK7 [6].
At time of diagnosis, the patient was 71 years old.
This differs significantly from the typical epidemiology of
mediastinal choriocarcinomas, which occurs primarily in
younger patients [7]. One might speculate that the long-term
treatmentwith goserelinmay have stimulated development of
the tumour, especially considering that GNRH receptors are
expressed in choriocarcinomas [8]. On the contrary, one in
vitro study found inhibitory properties of endogenousGNRH
in a single choriocarcinoma cell line [9]. However, these
results may only be extrapolated to goserelin with caution,
since synthetic GNRH agonists are 50 to 100 times more
potent than endogenous GNRH [10].
Insights into the potential carcinogenic properties of
goserelin and knowledge of expression of GNRH receptors
may be utilized in the diagnosis and treatment of choriocar-
cinomas.
3. Conclusion
Extragonadal choriocarcinomas are extremely rare germ cell
tumours, and diagnosis requires advanced immunohisto-
chemical analysis. The prognosis is usually poor, which
underlines the necessity of rapid diagnosis in order to
institute treatment before progression hinders treatment.
In this case report, we speculate that long-term treatment
with goserelin may have stimulated the development of the
choriocarcinoma.
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